IBT B Infant Bacterial Therapeutics AB OMXSTO · Sweden

Infant Bacterial Therapeutics AB (IBT B) news

Infant Bacterial Therapeutics AB is a public biotech or pharmaceutical company listed on OMXSTO under the ticker IBT_B, recorded under Sweden. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Infant Bacterial Therapeutics AB news

We have not published a story on Infant Bacterial Therapeutics AB yet. When there is news, it will appear here.

Questions about Infant Bacterial Therapeutics AB

What is the ticker symbol of Infant Bacterial Therapeutics AB?

Infant Bacterial Therapeutics AB trades under the ticker IBT_B on OMXSTO.

Where is Infant Bacterial Therapeutics AB listed?

Infant Bacterial Therapeutics AB is listed on OMXSTO. Our directory also records these other listings: LS:A2AFQL.

Which country or territory is Infant Bacterial Therapeutics AB listed under?

Our directory records Infant Bacterial Therapeutics AB under Sweden.

What does Infant Bacterial Therapeutics AB do?

Our directory classifies Infant Bacterial Therapeutics AB as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Infant Bacterial Therapeutics AB?

The ISIN recorded for Infant Bacterial Therapeutics AB is SE0008015259.

Does aibio.space cover Infant Bacterial Therapeutics AB?

aibio.space lists Infant Bacterial Therapeutics AB among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Infant Bacterial Therapeutics AB?

Companies in our directory listed in the same country and business area as Infant Bacterial Therapeutics AB: Hansa Biopharma AB, SynAct Pharma AB, Cantargia AB, Immunovia AB, Egetis Therapeutics AB, Moberg Pharma AB.

Investor discussion: Infant Bacterial Therapeutics AB

Members talk about Infant Bacterial Therapeutics AB (IBT_B). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OMXSTO:IBT_B on TradingView.

Listing details

Company: Infant Bacterial Therapeutics AB
Ticker: IBT_B
Listing: OMXSTO
Country or territory: Sweden
Business scope: Pharmaceuticals: Major
ISIN: SE0008015259
Other listed symbols: LS:A2AFQL
Last quote in directory: 2026-10-21
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction